Deepa Prasad, Director at Design Therapeutics, Inc. (DSGN), bought 12,000 shares at $2.31 ($28K) on 2023-08-29, disclosed to the SEC on 2023-08-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.